Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.
Identifying the targets of broadly neutralizing antibodies to HIV-1 and understanding how these antibodies develop remain important goals in the quest to rationally develop an HIV-1 vaccine. We previously identified a participant in the CAPRISA Acute Infection Cohort (CAP257) whose plasma neutralize...
Guardado en:
Autores principales: | Constantinos Kurt Wibmer, Jinal N Bhiman, Elin S Gray, Nancy Tumba, Salim S Abdool Karim, Carolyn Williamson, Lynn Morris, Penny L Moore |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c857a556c964276b43d258fe5d7a14d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
por: Megan K Murphy, et al.
Publicado: (2013) -
Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
por: Thomas Krey, et al.
Publicado: (2013) -
Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation
por: Erik L. Johnson, et al.
Publicado: (2018) -
Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data.
por: Andrew L Ferguson, et al.
Publicado: (2013) -
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Lorena Vigón, et al.
Publicado: (2019)